Affiliation:
1. Beslenme ve Diyetetik Bölümü, Acıbadem Mehmet Ali Aydınlar Üniversitesi Sağlık Bilimleri Fakültesi
2. Beslenme ve Diyetetik Bölümü, İstanbul Medipol Sağlık Bilimleri Fakültesi
Abstract
Aim: The aim of this study was to investigate the relationship between body mass index and serum visfatin and metabolic parameters in subjects with different body mass indexes.
Methods: Patients enrolled in this study were applied a questionnaire including their personal information, dietary habits and status of physical activities. Their length and body weight were measured, body mass indexes were calculated, and body fat percentage and waist circumference were measured. In addition, routine biochemical parameters (total cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol, VLDL-cholesterol, fasting blood glucose, fasting insulin) and serum visfatin levels of patients were measured, and they were evaluated according to their body mass indexes.
Results: Serum visfatin levels of patients were not found to be correlated with their age, gender and waist circumference, but a moderate negative correlation was determined with body fat percentage. Also there was a negative correlation between body mass indexes and serum visfatin level. While there was no statistically significant relation between serum visfatin level and cholesterol, triglyceride, HDL-cholesterol, LDL-cholesterol as well as VLDL-cholesterol, a negative correlation was found between serum visfatin and fasting glucose and fasting insulin levels.
Conclusion: Serum visfatin levels resulted lower in patients with high body mass indexes. Negative correlation between serum visfatin levels and fasting blood glucose as well as fasting blood insulin indicates that serum visfatin levels may be associated with the mechanism of insulin resistance in obesity.
Keywords: visfatin, body mass index, metabolic profile
Publisher
Eurasian Society of Family Medicine
Reference37 articles.
1. World Health Organization [internet]. WHO fact sheet on overweight and obesity. [cited 2019 Aug 6]. Available from: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
2. Ayla BE. Obezitenin kadın sağlığı ve toplumsal cinsiyet açısından değerlendirilmesi. Kashed 2014;1(1):41-54.
3. T.C. Sağlık Bakanlığı Türkiye Halk Sağlığı Kurumu. Türkiye kalp ve damar hastalıkları önleme ve kontrol programı. Ankara: Anıl Matbaacılık; 2015:15.
4. T.C. Sağlık Bakanlığı [internet]. Türkiye beslenme ve sağlık araştırması 2010: beslenme durumu ve alışkanlıklarının değerlendirilmesi sonuç raporu [cited 2019 Jun 5]. Available from: https://hsgm.saglik.gov.tr/depo/birimler/saglikli-beslenme-hareketli-hayat-db/Yayinlar/kitaplar/diger-kitaplar/TBSA-Beslenme-Yayini.pdf
5. Hatemi H, Turan N, Arık N, Yumuk V. Türkiye'de obezite ve hipertansiyon taraması sonuçları (TOHTA). Endokrinolojide Yönelişler Dergisi 2002;11(Ek-1):1-16.